Around the country, lanterns will light up the night sky, a symbolic moment to show the light of hope in dark times.
The Light the Night event, the main fundraiser for the Leukemia & Lymphoma Society, will be coming to Boca Raton on Nov. 10. A community event, teams and individuals raise money for research and support for cancer patients and their families.
“I am honored to be this year’s Corporate Walk Chair and presenting sponsor of the event,” says Will Ferrigno, the charity’s events chairman. “Having seen the struggles firsthand and personally felt the pain of losing a loved one, I stand by LLS in the fight to find a cure and encourage all local businesses to get involved.”
Across the United States and Canada, 1 million people participate in Light the Night at more than 150 events. Since 1949, the Leukemia & Lymphoma Society’s mission has been to cure blood cancers, such as leukemia, lymphoma, Hodgkin’s disease and myeloma. The charity also helps improve the lives of patients and their families as they battle their illness.
Prior to the event, teams created by families, friends and coworkers raise money with different charity drives to help fund research and programming. Already, teams and individuals have raised tens of thousands of dollars for the Leukemia & Lymphoma Society. This year, the Boca Raton event’s goal is to raise $300,000.
The registration for the free event begins at 5 p.m., with live entertainment for the whole family from 5:30 to 7:30 p.m. Then at 7:45 p.m., the official program and event will begin. People will carry illuminated lanterns in white, red, and gold by survivors, supporters, and those remembering loved ones they’ve lost, respectively. A Remembrance Pavilion will also be set up for friends and family to leave tributes.
“Together, we can take the steps to end cancer,” Ferrigno says.
The Boca Raton Light the Night Walk is Nov. 10 at the Mizner Park Amphitheater, 590 Plaza Real in Boca Raton. For more information, visit lightthenight.org/pb or call 561/616-8682.
This post is sponsored by the Leukemia and Lymphoma Society.